Cargando…

Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial

INTRODUCTION: Dexamethasone is a drug used to prolong the postoperative analgesia in children after peripheral nerve blockade, although the dose usually used (0.2 mg/kg) has not been studied yet. This study is a monocentric, prospective, randomised, placebo-controlled, double-blinded study in a univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Vautrin, Nicolas, Thilly, Nathalie, Bernard, Yohann, Wurtz, François, Meistelman, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528367/
https://www.ncbi.nlm.nih.gov/pubmed/32998920
http://dx.doi.org/10.1136/bmjopen-2020-036863
_version_ 1783589249081147392
author Vautrin, Nicolas
Thilly, Nathalie
Bernard, Yohann
Wurtz, François
Meistelman, Claude
author_facet Vautrin, Nicolas
Thilly, Nathalie
Bernard, Yohann
Wurtz, François
Meistelman, Claude
author_sort Vautrin, Nicolas
collection PubMed
description INTRODUCTION: Dexamethasone is a drug used to prolong the postoperative analgesia in children after peripheral nerve blockade, although the dose usually used (0.2 mg/kg) has not been studied yet. This study is a monocentric, prospective, randomised, placebo-controlled, double-blinded study in a university hospital in France. The primary objective of the study is to evaluate the efficacy of 0.2 mg/kg intravenous dexamethasone on early postoperative pain in children aged 6–15 years, who require a lower limb peripheral nerve block following general anaesthesia. METHODS AND ANALYSIS: Eighty children, aged 6–15 years, undergoing surgery for which peripheral nerve lower limb blockade with ropivacaine following general anaesthesia are included. The inclusion criteria are: children aged 6–15 years, with American Society of Anaesthesiologists physical status I or II and scheduled for surgery requiring a peripheral block of the lower limb for analgesic purposes, with a preoperative anaesthetic evaluation between 90 and 2 days before the surgery, with informed consent from legal representatives. General anaesthesia is performed. The patient receives, according to his group, either 0.2 mg/kg of dexamethasone intravenously at the start of anaesthetic induction or the same volume of placebo. Then, the peripheral block of the lower limb is performed with ropivacaine. The primary outcome is the total doses of opioid administered (in mg/kg of morphine equivalent) within 24 hours postoperatively. The secondary objectives are the evaluation of the effect of a single-dose intravenous dexamethasone at the time of anaesthetic induction, on the following parameters: onset of postoperative pain, duration of motor block, postoperative nausea and vomiting within 24 hours. ETHICS AND DISSEMINATION: This study is conducted according to the principles of the Declaration of Helsinki and has been approved by the French national ethics committee and the National Drug Safety Agency. Findings of this study will be widely disseminated through conference presentations, reports, factsheets and academic publications. TRIAL REGISTRATION NUMBER: NCT03618173.
format Online
Article
Text
id pubmed-7528367
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75283672020-10-19 Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial Vautrin, Nicolas Thilly, Nathalie Bernard, Yohann Wurtz, François Meistelman, Claude BMJ Open Anaesthesia INTRODUCTION: Dexamethasone is a drug used to prolong the postoperative analgesia in children after peripheral nerve blockade, although the dose usually used (0.2 mg/kg) has not been studied yet. This study is a monocentric, prospective, randomised, placebo-controlled, double-blinded study in a university hospital in France. The primary objective of the study is to evaluate the efficacy of 0.2 mg/kg intravenous dexamethasone on early postoperative pain in children aged 6–15 years, who require a lower limb peripheral nerve block following general anaesthesia. METHODS AND ANALYSIS: Eighty children, aged 6–15 years, undergoing surgery for which peripheral nerve lower limb blockade with ropivacaine following general anaesthesia are included. The inclusion criteria are: children aged 6–15 years, with American Society of Anaesthesiologists physical status I or II and scheduled for surgery requiring a peripheral block of the lower limb for analgesic purposes, with a preoperative anaesthetic evaluation between 90 and 2 days before the surgery, with informed consent from legal representatives. General anaesthesia is performed. The patient receives, according to his group, either 0.2 mg/kg of dexamethasone intravenously at the start of anaesthetic induction or the same volume of placebo. Then, the peripheral block of the lower limb is performed with ropivacaine. The primary outcome is the total doses of opioid administered (in mg/kg of morphine equivalent) within 24 hours postoperatively. The secondary objectives are the evaluation of the effect of a single-dose intravenous dexamethasone at the time of anaesthetic induction, on the following parameters: onset of postoperative pain, duration of motor block, postoperative nausea and vomiting within 24 hours. ETHICS AND DISSEMINATION: This study is conducted according to the principles of the Declaration of Helsinki and has been approved by the French national ethics committee and the National Drug Safety Agency. Findings of this study will be widely disseminated through conference presentations, reports, factsheets and academic publications. TRIAL REGISTRATION NUMBER: NCT03618173. BMJ Publishing Group 2020-09-30 /pmc/articles/PMC7528367/ /pubmed/32998920 http://dx.doi.org/10.1136/bmjopen-2020-036863 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Anaesthesia
Vautrin, Nicolas
Thilly, Nathalie
Bernard, Yohann
Wurtz, François
Meistelman, Claude
Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title_full Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title_fullStr Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title_full_unstemmed Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title_short Protocol of DEXPED trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
title_sort protocol of dexped trial: efficacy of intravenous dexamethasone, administered at the time of analgesic blocking of the lower limb, on postoperative pain in children: a randomised, placebo-controlled, double-blind trial
topic Anaesthesia
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528367/
https://www.ncbi.nlm.nih.gov/pubmed/32998920
http://dx.doi.org/10.1136/bmjopen-2020-036863
work_keys_str_mv AT vautrinnicolas protocolofdexpedtrialefficacyofintravenousdexamethasoneadministeredatthetimeofanalgesicblockingofthelowerlimbonpostoperativepaininchildrenarandomisedplacebocontrolleddoubleblindtrial
AT thillynathalie protocolofdexpedtrialefficacyofintravenousdexamethasoneadministeredatthetimeofanalgesicblockingofthelowerlimbonpostoperativepaininchildrenarandomisedplacebocontrolleddoubleblindtrial
AT bernardyohann protocolofdexpedtrialefficacyofintravenousdexamethasoneadministeredatthetimeofanalgesicblockingofthelowerlimbonpostoperativepaininchildrenarandomisedplacebocontrolleddoubleblindtrial
AT wurtzfrancois protocolofdexpedtrialefficacyofintravenousdexamethasoneadministeredatthetimeofanalgesicblockingofthelowerlimbonpostoperativepaininchildrenarandomisedplacebocontrolleddoubleblindtrial
AT meistelmanclaude protocolofdexpedtrialefficacyofintravenousdexamethasoneadministeredatthetimeofanalgesicblockingofthelowerlimbonpostoperativepaininchildrenarandomisedplacebocontrolleddoubleblindtrial